Ask Our Doctors – Archive

Our Medical Directors are outstanding physicians that you will find to be very personable and compassionate, who take care to ensure that you have the most cutting-edge fertility treatments at your disposal. This is your outlet to ask your questions to the doctors.

19,771 Comments

  1. Hi
    I have been to my GP & had my hcg levels tested on day 28 of my cycle. The levels were 140. She has told me that these are low levels & to retest in 2 weeks. I feel really anxious & am wondering if testing earlier would be possible?

    • I respectfully disagree! I think that hCG level is promising!

      Geoff Sher

  2. Hi doctor Sher I hope you’re having a lovely weekend. My question is do you have your patients take stims such as gonal f/follistim and then the cetrotide the same day as trigger shot? If so what is the purpose of this?

    • Martha,

      The GnRH antagonist (Cetrotide/Ganirelix/Orgalutron) is started some time before the trigger. Its role is to suppress the LH release from occurring prematurely.

      We need to discuss your specific circumstances. I suggest you call my assistant, Patti at 702-533-2691 and set up an online consultation with me.

      Geoff Sher

  3. Hi, I have a 5 year history of infertility with PCOS, one ectopic pregnancy (lost tube), many try’s with fertility drugs and 4 unsuccessful IUI’s. I recently had a hysteroscopy to remove scare tissue (unknown reason why I had it). Well I recently found out I was pregnant, on accident and completely natural. My first hcg, exactly 14 days after conception was 50. That was two days ago. My hcg today was only 66. So I didn’t even rise by 60%. This is exactly what happened with my ectopic before…I will be getting bloodwork again in 2 days. But do you think this pregnancy could still be viable? The nurse said it doesn’t look good. But I have yet to be able to speak to my doctor. What do you think?

    • Unfortunately this pregnancy is failing. We need to talk,

      For about 10% of all infertile couples, the cause of the infertility cannot be readily determined using conventional diagnostic methods. Such cases are often referred to as “unexplained infertility.” The truth however is that in most such cases, the diagnosis of “unexplained infertility is in fact “presumptive because a more in-depth evaluation would have revealed a cause. This having been said, people diagnosed with so called “unexplained infertility” fall into two broad groups: a)those couples who don’t have any biological problems interfering with pregnancy and, b) those who do but the reason cannot be found due to insufficient medical information or technology. It is in this latter group that improved testing techniques have made infertility easier to diagnose and treat.
      In order to make even a presumptive diagnosis of “unexplained infertility” the answers to the following questions must be in the affirmative.
      ?Is the woman ovulating normally?
      ?Is the couple having intercourse regularly in the periovulatory phase of the cycle?
      ?Are the fallopian tubes normal and open?
      ?Can endometriosis be excluded?
      ?Does the male partner have normal semen parameters (most specifically with regard to sperm count and motility?
      ?Is the post coital (Huhner) test (periovulatory examination of cervical mucous, done 6-18 hours after intercourse) normal?
      The definitive diagnosis of “unexplained infertility” has a lot to do with the thoroughness of the health care provider in excluding all possible causes. The fewer tests performed, the more likely a presumptive diagnosis
      For Example:
      ?Abnormalities of the fallopian tubes (adhesions or developmental defects) of the finger-like “petals” at their outer ends of the tubes that help sweep eggs inside (i.e. fimbriae). can prevent eggs from being collected and transported to the awaiting sperm
      ?Chromosomal abnormalities of eggs or embryos: Eggs must be euploid (contain the right number of chromosomes) to be successfully fertilized and embryos must also be euploid in order to implant successfully in the uterine lining. Until recently there was no reliable method for determining whether eggs and embryos were euploid. The recent introduction of genetic tests such as comparative genomic hybridization (CGH) now allows for identification of all chromosomes in the egg and embryo. As such CGH represents an important addition to the “infertility” diagnostic armamentarium.
      ?Luteinized Unruptured Follicle (LUF)Syndrome: Here, the eggs can become trapped in the follicle and not be released (trapped ovulation) In such cases routine tests done to detect ovulation ((temperature charting, Urine LH testing, Blood progesterone levels) may be normal resulting in false interpretation that ovulation is actually occurring.
      ?Ovulation (hormonal) Dysfunction: Abnormalities in ovarian hormone production in the preovulatory phase of the cycle (follicular phase defect) and/or in the postovulatory phase (luteal phase defect) can negatively affect preparation of the uterine lining (endometrium), thus thwarting normal implantation.
      ?Immunologic implantation dysfunction (IID): Sometimes, the woman’s or the man’s own immune system can attack sperm cells, killing them or causing them to become immobilized. Also, immunologic dysfunction involving the uterine lining can cause the implanting embryo to be rejected so early that the woman does not even recognize that she in fact had conceived.
      ?Cervical infection; Ureaplasma urealyticum infection of the cervical glands can prevent sperm from migrating through the cervix and uterus to reach the egg(s) in the fallopian tube(s). Such infection will usually not be detectable through routine examination and/or cervical culturing methods.
      ?Mild or Moderate Endometriosis: Endometriosis is in 100% of cases associated with the production of “pelvic toxins” that reduce the fertilization potential of otherwise normal eggs by a factor of 3-5. In addition, about 1/3 of woman with endometriosis (regardless of its severity) have immunologic implantation dysfunction (IID). Furthermore mild and often even moderately severe endometriosis can only be accurately diagnosed by direct visualization of the lesions through laparoscopy or laparotomy and, the detection of IID requires highly sophisticated tests that can only be adequately performed by a handful of Reproductive Immunology Reference Laboratories in the United States. Finally, a condition called nonpigmented endometriosis, in which the endometrium may be growing inside the pelvic cavity with many of the same deleterious effects as overt endometriosis, cannot be detected even by direct vision (at laparoscopy/laparotomy). The fertility of these patients may be every bit as compromised as if they had detectable endometriosis.
      ?Psychological Factors: The entire reproductive process is governed by the brain. Thus it should come as no surprise that stress and negativity can interfere with hormonal balance and decrease the ability to conceive.
      ?Mild Male Factor
      ?Antisperm antibodies in the man or woman.
      Management:
      Successful management of “Unexplained Infertility” requires that a very individualized approach be taken. Wherever possible the underlying cause should first be identified. Problems that involve ovulation dysfunction (hormonal imbalance) require ovulation induction with oral or injectible fertility drugs. Cervical mucous hostility due to infection with ureaplasma (which is transferred back and forth sexually to both partners) requires specific and concurrent antibiotic therapy. In other cases involving younger women (under 39 years) where there is a problem with sperm migration via the cervix and uterus to the fallopian tube(s) intrauterine insemination (IUI) with or without ovulation induction, is indicated. When these treatments fail, in cases, women over the age of 39 years, in women with IID, in men or women who harbor antisperm antibodies in significant concentrations and in cases associated with tubal abnormalities, in vitro fertilization (IVF) is needed. All cases of intractable, moderate or severe male infertility call for injecting sperm directly into the egg to achieve forced fertilization (intracytoplasmic sperm injection-ICSI).
      It is an indisputable fact that most causes of infertility can be diagnosed and it is a great pity that the diagnosis of “unexplained infertility” is often used as an excuse for not having performed a full and detailed evaluation of the problem. Couples should not simply accept a diagnosis of “unexplained infertility” at face value since treatment is most likely to be successful when the specific cause of the problem can be fully identified
      I strongly recommend that you visit http://www.SherIVF.com. Then go to my Blog and access the “search bar”. Type in the titles of any/all of the articles listed below, one by one. “Click” and you will immediately be taken to those you select. Please also take the time to post any questions or comments with the full expectation that I will (as always) respond promptly.

      •A Fresh Look at the Indications for IVF
      •The IVF Journey: The importance of “Planning the Trip” Before Taking the Ride”
      •Controlled Ovarian Stimulation (COS) for IVF: Selecting the ideal protocol
      •IVF: Factors Affecting Egg/Embryo “competency” during Controlled Ovarian Stimulation(COS)
      •The Fundamental Requirements For Achieving Optimal IVF Success
      •Use of GnRH Antagonists (Ganirelix/Cetrotide/Orgalutron) in IVF-Ovarian Stimulation Protocols.
      •Human Growth Hormone Administration in IVF: Does it Enhances Egg/Embryo Quality and Outcome?
      •IVF and the use of Supplementary Human Growth Hormone (HGH) : Is it Worth Trying and who needs it?
      •The BCP: Does Launching a Cycle of Controlled Ovarian Stimulation (COS). Coming off the BCP Compromise Response?
      •Blastocyst Embryo Transfers Should be the Standard of Care in IVF
      •Anti Mullerian Hormone (AMH) Measurement to Assess Ovarian Reserve and Design the Optimal Protocol for Controlled Ovarian Stimulation (COS) in IVF.
      •IVF: Approach to Selecting the Best Embryos for Transfer to the Uterus.
      •Fresh versus Frozen Embryo Transfers (FET) Enhance IVF Outcome
      •Frozen Embryo Transfer (FET): A Rational Approach to Hormonal Preparation and How new Methodology is Impacting IVF.
      •Genetically Testing Embryos for IVF
      •Staggered IVF
      •Staggered IVF with PGS- Selection of “Competent” Embryos Greatly Enhances the Utility & Efficiency of IVF.
      •Preimplantation Genetic Testing (PGS) in IVF: It should be Used Selectively and NOT be Routine.
      •IVF: Selecting the Best Quality Embryos to Transfer
      •Preimplantation Genetic Sampling (PGS) Using: Next Generation Gene Sequencing (NGS): Method of Choice.
      •PGS in IVF: Are Some Chromosomally abnormal Embryos Capable of Resulting in Normal Babies and Being Wrongly Discarded?
      •PGS and Assessment of Egg/Embryo “competency”: How Method, Timing and Methodology Could Affect Reliability
      •Endometrial Receptivity Array (ERA): Is There an actual “There, There”?
      •IVF Failure and Implantation Dysfunction:
      •Diagnosing and Treating Immunologic Implantation Dysfunction (IID)
      •The Role of Immunologic Implantation Dysfunction (IID) & Infertility (IID):PART 1-Background
      •Immunologic Implantation Dysfunction (IID) & Infertility (IID):PART 2- Making a Diagnosis
      •Immunologic Dysfunction (IID) & Infertility (IID):PART 3-Treatment
      •Thyroid autoantibodies and Immunologic Implantation Dysfunction (IID)
      •Immunologic Implantation Dysfunction: Importance of Meticulous Evaluation and Strategic Management:(Case Report
      •Intralipid and IVIG therapy: Understanding the Basis for its use in the Treatment of Immunologic Implantation Dysfunction (IID)
      •Intralipid (IL) Administration in IVF: It’s Composition; How it Works; Administration; Side-effects; Reactions and Precautions
      •Natural Killer Cell Activation (NKa) and Immunologic Implantation Dysfunction in IVF: The Controversy!
      •Endometrial Thickness, Uterine Pathology and Immunologic Factors
      •Vaginally Administered Viagra is Often a Highly Effective Treatment to Help Thicken a Thin Uterine Lining
      •A Thin Uterine Lining: Vaginal Viagra is Often the Answer (update)
      •Cervical Ureaplasma Urealyticum Infection: How can it Affect IUI/IVF Outcome?
      •The Role of Nutritional Supplements in Preparing for IVF
      •The Basic Infertility Work-Up
      •Defining and Addressing an Abnormal Luteal Phase
      •Male Factor Infertility
      •Routine Fertilization by Intracytoplasmic Sperm Injection (ICSI): An Argument in Favor
      •Hormonal Treatment of Male Infertility
      •Hormonal Treatment of Male Infertility
      •Antisperm Antibodies, Infertility and the Role of IVF with Intracytoplasmic Sperm Injection (ICSI)
      •Endometriosis and Infertily
      •Endometriosis and Immunologic Implantation Dysfunction (IID) and IVF
      •Endometriosis and Infertility: Why IVF Rather than IUI or Surgery Should be the Treatment of Choice.
      •Endometriosis and Infertility: The Influence of Age and Severity on Treatment Options
      •Early -Endometriosis-related Infertility: Ovulation Induction (with or without Intrauterine Insemination) and Reproductive Surgery Versus IVF
      •Deciding Between Intrauterine Insemination (IUI) and In Vitro Fertilization (IVF).
      •Intrauterine Insemination (IUI): Who Needs it & who Does Not: Pro’s & Con’s!IUI-Reflecting upon its Use and Misuse: Time for a Serious “Reality Check
      •Mode of Action, Indications, Benefits, Limitations and Contraindications for its ue
      •Clomiphene Induction of Ovulation: Its Use and Misuse!

      ADDENDUM: PLEASE READ!!
      INTRODUCING SHER FERTILITY SOLUTIONS (SFS)
      Founded in April 2019, Sher Fertility Solutions (SFS) offers online (Skype/FaceTime) consultations to patients from > 40 different countries. All consultations are followed by a detailed written report presenting my personal recommendations for treatment of what often constitute complex Reproductive Issues.

      If you wish to schedule an online consultation with me, please contact my assistant (Patti Converse) by phone (800-780-7437/702-533-2691), email (concierge@SherIVF.com) or, enroll online on then home-page of my website (www.SherIVF.com).

      PLEASE SPREAD THE WORD ABOUT SFS!

      Geoff Sher

  4. Hi Dr. Sher,

    I have another question, hope you don’t mind.
    My first IVF cycle, the PGT-A results on 2 of the embryos from day 5 blast came back abnormal.
    results:
    abnormal -13
    complex abnormal -16 & +17
    We didn’t transfer any and the grading was 4BB 4CC.
    If the trophectoderm is B or C, does that mean you always will get at least 1 chromosome defect? or with B you can get normal embryos too?
    In your opinion, did we make the right choice for not transferring them?

    Thank you so much!

    • You can get normal embryos in both B or C situations.

      Geoff Sher

  5. There is a link between quality and grading but the older the woman, the more likely it is that the embryo will ne aneuploid (incompetent) and unable to propagate a normal conceptus. By way of example…At age 35, roughly 1: 3 eggs/embryos are euploid (competent). At 40y, about 1: 5 and at 45y…about 1: 25. pregnancy. So, regardless of the embryo’s grade,the woman’s age, impacts egg, and therefore embryo “competency”. Separately, embryos that don’t reach blastocyst by day 6 post fertilization are almost invariably, “incompetent”.

    Expanded blastocysts that are chromosomally euploid (PGT-A normal) are far more likely to be “competent” , regardless of age.

    Geoff Sher